Mozart Therapeutics Unveils Promising Data on MTX-101 for Type 1 Diabetes at EASD 2026 #United_States #Seattle #Type_1_Diabetes #Mozart_Therapeutics #MTX-101
@newsen.bsky.social
@newsen.bsky.socialMozart Therapeutics Unveils Promising Data on MTX-101 for Type 1 Diabetes at EASD 2026 #United_States #Seattle #Type_1_Diabetes #Mozart_Therapeutics #MTX-101
@newsen.bsky.socialBreakthrough T1D Hosts First Clinical Congress Addressing Type 1 Diabetes #United_States #Philadelphia #Type_1_Diabetes #Clinical_Research #Breakthrough_T1D
@newsen.bsky.socialBreakthrough Guidance Introduces Screening for Early-Stage Type 1 Diabetes in General Populations #USA #New_York #Type_1_Diabetes #Diabetes_Care #Health_Screening